Fear of Cancer Recurrence Contributes Largely to Patient Anxiety and Depression and Quality of Life in a Prospective Cohort of Chinese Breast Cancer Patients for Postoperative Radiotherapy
The Breast Journal · 2025-01 · 2025 (1)
DOI: 10.1155/tbj/5788053 ↗Abstract
Background Fear of cancer recurrence (FCR) is common among Chinese breast cancer (BC) patients following surgery, chemotherapy, and radiotherapy (RT). Understanding the prevalence and impact of FCR, particularly during the RT period, on anxiety, depression, and quality of life may inform strategies to manage patient distress. Methods From July 2015 to December 2016, 486 women undergoing RT for BC at the Fourth Hospital of Hebei Medical University, China, were prospectively enrolled in the study. Anxiety, depression, and quality‐of‐life changes were assessed using the Hospital Anxiety and Depression Scale (HADS) and the European Organization for Research and Treatment of Cancer’s Quality‐of‐Life questionnaires (QLQ‐C30, QLQ‐BR23) before and after RT. FCR was assessed using a modified question from the QLQ‐BR23, “how much have you worried about tumor recurrence (over the last week),” which demonstrated the satisfactory construct validity and reliability in a prior pilot study. ANOVA, multivariate linear regressions, and ordinal logistic regressions were performed to evaluate odds ratio (OR) and p values. Pain and sleep disturbance were included as covariates in secondary models. Results Of the 486 women enrolled, 23 (4.7%) patients declined participation. Of the 463 analyzed patients, the mean age was 47 years old. 386 patients (83.4%) elected for mastectomies. FCR levels prior to RT were reported as “ none ” (29.4%), “ a little bit ” (51.2%), “ some ” (12.1%), and “ very much ” (7.3%). Increased FCR severity was associated with elevated median anxiety score (1.5, 5.0, 7.0, 8.5) and increased rates of clinically significant anxiety (anxiety score ≥ 11; 0%, 3.4%, 12.5%, 26.5%). Similarly, median depression scores (2.0, 4.0, 6.0, 6.5) rose with FCR severity, accompanied by higher prevalence of atypical depression (depression score ≥ 11; 2.2%, 3.4%, 5.4%, 17.7%) (all p < 0.001). Compared to the reference “ none,” each unit increase of FCR severity was independently associated with one category (“ normal ,” “ borderline ,” and “ abnormal ”) of increased anxiety with OR ( p ) of 2.593 ( p = 0.011), 5.889 ( < 0.001 ), and 14.621 ( < 0.001 ) and increased depression with OR ( p ) of 2.406 ( 0.008 ), 3.045 ( 0.009 ), and 7.210 ( < 0.001 ), respectively. FCR severity was negatively associated with most quality‐of‐life domains ( p < 0.05). Similar associations persisted post RT. Conclusions FCR is a significant contributor to psychological distress and reduced quality of life among Chinese breast cancer patients during the RT period. Routine screening for anxiety and depression and targeted intervention for FCR should be prioritized in this population.
EUVIMED